{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:31:06Z","timestamp":1770895866489,"version":"3.50.1"},"reference-count":29,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2014,5,28]],"date-time":"2014-05-28T00:00:00Z","timestamp":1401235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p><jats:italic><jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>abesia microti,<\/jats:italic> a transfusion\u2010transmissible intraerythrocytic parasite, is increasing in frequency in the <jats:styled-content style=\"fixed-case\">U<\/jats:styled-content>nited <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>tates with no available <jats:styled-content style=\"fixed-case\">FDA<\/jats:styled-content>\u2010licensed donor screening assay. We utilized investigational arrayed fluorescence immunoassay (<jats:styled-content style=\"fixed-case\">AFIA<\/jats:styled-content>) and polymerase chain reaction (<jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content>) to detect <jats:italic><jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>.\u2009microti<\/jats:italic> antibodies and <jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content> in blood donors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study Design and Methods<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">AFIA<\/jats:styled-content> and real\u2010time <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content> were performed on frozen paired <jats:styled-content style=\"fixed-case\">EDTA<\/jats:styled-content> plasma (<jats:styled-content style=\"fixed-case\">AFIA<\/jats:styled-content>) and <jats:styled-content style=\"fixed-case\">EDTA<\/jats:styled-content> whole blood (<jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content>) samples collected from <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>ay to <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>eptember 2010 to 2011 in nonendemic (<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>rizona [<jats:styled-content style=\"fixed-case\">AZ<\/jats:styled-content>] and <jats:styled-content style=\"fixed-case\">O<\/jats:styled-content>klahoma [<jats:styled-content style=\"fixed-case\">OK<\/jats:styled-content>]), moderately endemic (<jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>innesota [<jats:styled-content style=\"fixed-case\">MN<\/jats:styled-content>] and <jats:styled-content style=\"fixed-case\">W<\/jats:styled-content>isconsin [<jats:styled-content style=\"fixed-case\">WI<\/jats:styled-content>]), and highly endemic (<jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>onnecticut [<jats:styled-content style=\"fixed-case\">CT<\/jats:styled-content>] and <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>assachusetts [<jats:styled-content style=\"fixed-case\">MA<\/jats:styled-content>]) areas of the <jats:styled-content style=\"fixed-case\">U<\/jats:styled-content>nited <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>tates. <jats:styled-content style=\"fixed-case\">AFIA<\/jats:styled-content> utilized <jats:italic><jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>.\u2009microti<\/jats:italic> piroplasm as an antigen substrate; <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content> primers and probes targeted the <jats:italic><jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>.\u2009microti<\/jats:italic> 18<jats:styled-content style=\"fixed-case\">S<\/jats:styled-content> ribosomal <jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content> gene. Data from <jats:styled-content style=\"fixed-case\">AZ<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">OK<\/jats:styled-content> were used to calculate specificity. All <jats:styled-content style=\"fixed-case\">AFIA<\/jats:styled-content>\u2010 or <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content>\u2010positive or \u2010inconclusive donors were deferred, notified, and invited to participate in a follow\u2010up study involving repeat testing and a demographic and risk\u2010factor questionnaire. Recipient tracing was performed for any cellular component transfused at index, at subsequent donation, or within the prior 12 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Testing of 13,269 paired samples included 4022 from <jats:styled-content style=\"fixed-case\">AZ<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">OK<\/jats:styled-content>, 4167 from <jats:styled-content style=\"fixed-case\">MN<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">WI<\/jats:styled-content>, and 5080 from <jats:styled-content style=\"fixed-case\">CT<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">MA<\/jats:styled-content>. <jats:italic><jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>.\u2009microti<\/jats:italic> antibody and\/or <jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content> prevalences were 0.025% (95% confidence interval [<jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>], 0.00%\u20100.14%), 0.12% (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>, 0.04%\u20100.28%), and 0.75% (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>, 0.53%\u20101.03%) in the nonendemic, mid\u2010endemic, and high\u2010endemic regions, respectively. Specificities were 99.95% (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>, 99.82%\u201099.99%) at a 1\u2010in\u201064 <jats:styled-content style=\"fixed-case\">AFIA<\/jats:styled-content> cutoff and 99.98% (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>, 99.86%\u2010100.00%) at a 1\u2010in\u2010128 cutoff.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p><jats:italic><jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>.\u2009microti<\/jats:italic> prevalence followed expected geographical patterns. Screening was feasible with a performance comparable or superior to other infectious disease blood donor screening assays.<\/jats:p><\/jats:sec>","DOI":"10.1111\/trf.12693","type":"journal-article","created":{"date-parts":[[2014,5,28]],"date-time":"2014-05-28T10:28:42Z","timestamp":1401272922000},"page":"2226-2236","source":"Crossref","is-referenced-by-count":55,"title":["Investigational screening for <i><scp>B<\/scp>abesia microti<\/i> in a large repository of blood donor samples from nonendemic and endemic areas of the <scp>U<\/scp>nited <scp>S<\/scp>tates"],"prefix":"10.1111","volume":"54","author":[{"given":"Erin D.","family":"Moritz","sequence":"first","affiliation":[{"name":"Scientific Support Office American Red Cross  Gaithersburg Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen S.","family":"Winton","sequence":"additional","affiliation":[{"name":"Scientific Support Office American Red Cross  Gaithersburg Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie T.","family":"Johnson","sequence":"additional","affiliation":[{"name":"American Red Cross Blood Services, Connecticut Region  Farmington Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Krysztof","sequence":"additional","affiliation":[{"name":"Scientific Support Office American Red Cross  Gaithersburg Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca L.","family":"Townsend","sequence":"additional","affiliation":[{"name":"Scientific Support Office American Red Cross  Gaithersburg Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Foster","sequence":"additional","affiliation":[{"name":"Scientific Support Office American Red Cross  Gaithersburg Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Devine","sequence":"additional","affiliation":[{"name":"Research Division IMUGEN, Inc.  Norwood Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Molloy","sequence":"additional","affiliation":[{"name":"Research Division IMUGEN, Inc.  Norwood Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Brissette","sequence":"additional","affiliation":[{"name":"Research Division IMUGEN, Inc.  Norwood Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor P.","family":"Berardi","sequence":"additional","affiliation":[{"name":"Research Division IMUGEN, Inc.  Norwood Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Stramer","sequence":"additional","affiliation":[{"name":"Scientific Support Office American Red Cross  Gaithersburg Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,5,28]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197010152831607"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197710132971511"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/00034983.1998.11813307"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpara.2008.03.001"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1202018"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.13.3.451-469.2000"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198011063031906"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02317.x"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02380.x"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03345.x"},{"key":"e_1_2_8_12_1","first-page":"509","article-title":"Transfusion\u2010transmitted babesia spp.: bull's eye on Babesia microti","volume":"155","author":"Leiby DA","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02279.x"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-155-8-201110180-00362"},{"key":"e_1_2_8_15_1","first-page":"505","article-title":"Babesiosis surveillance\u201418 states, 2011","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_8_16_1","first-page":"669","article-title":"Final 2012 reports of nationally notifiable infectious diseases","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/73.1.107"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1978.27.14"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja11.11378"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1907.121593"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02430.x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12125"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2012.03948.x"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2012.03612.x"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.00609.x"},{"key":"e_1_2_8_26_1","first-page":"42","article-title":"Determination of seroprevalence of Babesia microti (Bm) in endemic and non\u2010endemic blood donor populations using an investigational ELISA [abstract]","volume":"53","author":"Levin AE","year":"2013","journal-title":"Transfusion"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02429.x"},{"key":"e_1_2_8_28_1","first-page":"13A","article-title":"Prospective investigational blood donation screening for Babesia microti [abstract]","volume":"53","author":"Moritz E","year":"2013","journal-title":"Transfusion"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.29.1.1-4.1991"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.29.12.2779-2783.1991"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftrf.12693","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.12693","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T01:42:03Z","timestamp":1696210923000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.12693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,28]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.1111\/trf.12693"],"URL":"https:\/\/doi.org\/10.1111\/trf.12693","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,28]]}}}